![Karl Deisseroth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karl Deisseroth is the founder of Stellaromics, Inc. (2022), ClearLight Biotechnologies LLC (2014), and MapLight Therapeutics, Inc. (2018).
Dr. Deisseroth is currently an Advisor at Nan Fung Life Sciences.
Dr. Deisseroth holds a doctorate from Stanford University.
| Sociétés | Poste | Début |
|---|---|---|
Nan Fung Life Sciences
 Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences invests in companies located across the globe. The firm focuses on life sciences sectors such as health technology, biotechnology, pharmaceuticals, electrical instruments and medical services. It provides financing for seed, early and growth stage capital requirements. | Consultant / Advisor | - |
| Sociétés | Poste | Fin |
|---|---|---|
| MAPLIGHT THERAPEUTICS, INC. | Fondateur | - |
ClearLight Biotechnologies LLC
 ClearLight Biotechnologies LLC BiotechnologyHealth Technology Develops and commercializes tissue clearing technology | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ClearLight Biotechnologies LLC
ClearLight Biotechnologies LLC BiotechnologyHealth Technology Develops and commercializes tissue clearing technology | Health Technology |
Nan Fung Life Sciences
Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences invests in companies located across the globe. The firm focuses on life sciences sectors such as health technology, biotechnology, pharmaceuticals, electrical instruments and medical services. It provides financing for seed, early and growth stage capital requirements. | Finance |
MapLight Therapeutics, Inc.
 MapLight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for debilitating central nervous system disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
